We present the case of a -year-old female patient with microscopic polyangiitis presented with polyneuropathy of lower extremities and rapidly progressive glomerulonephritis. Disease had started as a pain and weakening of muscular strength fi rst in the left and than in the right leg. Electromiography has shown that a mainly dominant neurological aff ection was paresis of peroneal nerve in both lower extremities. In laboratory examination the titer of anti-myeloperoxidase anti-neutrophilic cytoplasmic antibodies (p-ANCA) was elevated. Due to renal involvement presented as a microscopic haematuria and decreasing of renal function, patient undergone kidney biopsy. It confi rmed the immune vasculitis microscopic polyangiitis type with ANCA-associated glomerulonephritis. Th is is one of rare case of microscopic polyangiitis without lung simptomatology, fi rst presented with asymmetrical polineuropathy of lower extremities. Th e patient was treated with methylprednisolone and cyclophosphamide in dosis adjusted to the level of disease severity and the renal function (methylprednisolone  mg/kg of body weight for two months with gradually tapering to the minimum eff ective dose and cyclophosphamide  mg/kg of body weight). Th is treatment lead to the partial remission of disease. In maintenance therapy azathioprin was introduced instead of cyclophosphamide.
INTRODUCTION
ANCA-associated glomerulonephritis is rapidly progressive glomerulonephritis characterised by the absence of immune deposits in biopsied kidney tissue (pauci-immune glomerulonephritis) and rapidly progressive deterioration of renal function [] . Th e elevated titer of anti-myeloperoxidase ANCA is very important immunological indicator. Disease can be limited only on kidney aff ecting a small vessels of kidney (idiopatic necroticans glomerulonephritis with crescents) or associated with systemic ANCA-positive vasculitis which aff ects a small vessels of kidney and more organ systems [] . According to Th e Chapel Hill Consensus Conference from , in ANCA vasculitis were included Wegener granulomatosus, microscopic polyangiitis and Churg-Strauss syndrome [] . ANCA vasculitis is the most common cause of rapidoprogressive necroticant glomerulonephritis with crescents infiltration. In this article we present a patient with ANCA vasculitis microscopic polyangiitis type who started with polyneuropathy of lower extremities six months before symptoms of kidney injury appeared.
Case Report
A -year-old female was admitted to the Clinic of Nephrology in Clinical Center University of Sarajevo on  th March  due to increased serum creatinine. She was previously hospitalised at the Clinic of Neurology from  th February  to  th March  due to polyneuropathy of lower extremities with unclear etiology. Neurological symptoms started in July  as paresthesio followed by pain in the left heel, which then spread, to the whole foot and subsequently to the lower leg. In November  the same symptoms appeared in the right leg, with the same pattern like the left one. Walking became problematic with symptoms worsening. Patient did not have raised temperature, sweating, headache, nor loss of consciousness. All other organic systems functioned normally. Over the previous two months blood pressure was raised. Patient has been smoking two large packs of cigarettes a day for the last  years. She has no previous kidney disease. Patient's medical documentation confi rmed that blood urea nitrogen (BUN) and serum creatinine levels in the last three months were within normal physiological limits.
Neurological examination and electromyogram (EMG) at Clinic of Neurology severe polyneuropathy and pronounced paresis of left peroneal nerve were found. Lumbo-sacral spine X-ray revealed a small disc herniation on L/L. Head MRI revealed an aftermath of cerebro-vascular damage due to lacunar thrombosis. On admission to the Clinic of Nephrology, physical examination revealed that patient was fully conscious, afebrile, eupnoic, without a skin rash and peripheral limphodenopathy or organomegaly. Auscultatory heart sounds were rhythmic, without murmurs. Blood pressure was increased (/ mmHg). Breath sounds were also normal. The patient didn't have back pain nor peripheral oedema. Neurological examination revealed weak gross motor function, especially of lower extremities, and pronounced paresis of the left peroneal nerve. Pulsations of the arteries on the feet bilateraly were a bit less palpable. Blood test results showed anaemia (haemoglobin . g/L) and accelerated eritrocyte sedimentation rate ( mm/h). Concentrations of serum creatinine ( μmol/L) and BUN (. mmol/L) were increased while creatinine clearance was decreased to . ml/min. Kidney ultrasound revealed increased echo of kidney parenhima, with signifi cant reduction of arterial branches on cortex periphery, especially on the left. These pointed to a chronic kidney disease of unknown etiology with laesioned kidney function. Lung examination was normal by Xray and spirometric test. Repeated EMG again confirmed severe polyneuropathy of lower extremities. Color Doppler analysis on large arteries of lower extremities showed atherosclerotic changes without a hemodynamic meaning. Immunological blood tests were revealed negative results for antinuclear factor, anti-ds DNA antibodies and crioglobuline. Titers of p-ANCA (antineutrofilic) antibodies and circulated immune complexes were elevated with increased C-reactive protein (Table ) . Tumour markers were negative and imunophenotipisation of peripheral blood did not show any change in the number of T lymphocytes, their subpopularisation and B lymphocytes. Elevated serum creatinine and BUN, proteinuria of . g/d, microscopic hematury, granulated urinary cylinders and very elevated titer p-ANCA antibodies indicated to the affection of kidneys within systemic infl ammation most likely of vasculitis type. Kidney biopsy was performed and proved that more than  of glomerules in the tissue sample were globally sclerotic. In two non-sclerotic glomerules extracapillary proliferation was found ( Figure ) . Capillary lumen thromb and microscopic focus of fibrinoid necrosis of capillary wall were found in one glomerule ( Figure ) . In one interlobar and a couple of arteries of small calibre there was interruption in the continuity of elastic lamina ( Figure ) . Diff use cellular infi ltration of interstitium was made of CD positive lymphocytes, with some B lymphocytes as well as plasma cells and eosinofi lic leukocytes. In tubules was atrophy of epithelium, focaly and in part diff use ( Figure ) . Immune deposits were not found by immunofluorescency. Distinct tubulointersticial and periglomerular inflammation, focal fibrinoid necrosis of capillary wall and chronic diffused sclerotic glomerulonephritis with crescent cellular proliferation in  of glomerules were morphological confirmation of weakened immune vasculitis most likely of microscopic polyangiitis type. The patient treatment was started with methylprednisolone in dose of  mg/kg of body weight with gradually tapering to the dose of maintenance and cyclophosphamide in dose of  mg/kg of body weight, as the patient had very low creatinine clearance (. ml/min). Two months after the start of therapy kidney function improved with creatinine clearance . ml/min and signifi cant reduction in titer of p-ANCA antibodies to .. Neurological problems in legs became less pronounced. Five months after the start of the treatment blood test results showed persistence of partial remission of disease (Table ) . EMG revealed signifi cant improvement of neurophysiological parameters so kinesitherapy was recommended. Th e patients was converted to the maintenance therapy: oral prednisolone . mg/ kg of body weight and azathioprin  mg/kg of body weight.
DISCUSSION
Microscopic polyangiitis (MPA) is a very rare disease characterized by the lesions of arteriolae, venulae and capillaries, as well as medium arteries mainly of the kidneys and lungs, but also of other systems and organs [] . The reported incidence of MPA in Europe is from . per million in Norway [] to . per million in Spain [] . Peak incidence of microscopic polyangiitis is between - years of life. Small vessels vasculitis connected with ANCA are idiopathic diseases of unknown etiology.
In our  years old female patient this type of vasculitis was related to the polyneuropathy of lower extremities and rapidly progressive glomerulonephritis with development of renal failure. ANCA glomerulonephritis is the most common complication of the disease. It is presented in half of patients on the start of the disease progressing to  of patients during course of illness. Microscopic polyangiitis mainly affects small-calibre vessels of the kidneys and lungs [] . Systemic small vessels vasculitis often begins with high temperature, loss of weight, arthralgias, usually with symptoms of upper and lower respiratory system, skin changes and problems related with musculoskeletal system [] . Th ese symptoms had not been found in our patient except mialgias and weakened of lower extremities. Compared the clinical aspects of peripheral neuropathy associated with Wegener's granulomatosis ( patients), Churg-Strauss syndrome ( patients) and microscopic polyangiitis ( patients) in a single center cohort study conducted between  and , Cattaneo et al. were confi rmed peripheral neuropathy in / patients [] . Neuropathy occured earlier and presented with severe form of mononeuritis multiplex in patients with MPA compared to patients with Wegener's granulomatosis. Electrophysiologic findings and sural nerve biopsy confirmed acute axonal changes in MPA [] . Zhang et al. were observed nervous system involvement in .  of MPA patients [] . Microscopic polyangiitis includes mainly mononeuritis multiplex or distal symmetrical polyneuropathy [, ] . Presentation of asymmetrical polyneuropathy of lower extremities for six months before kidney symptoms in our patient could be independent of kidney as idiopathic polyneuropathy or as a first manifestation of an atypical presentation of MPA. Kaaroud et al. described a woman with rapidly progressive glomerulonephritis, who was presented with partial loss of motor and sensory function in both lower limbs with sphincter dysfunction seven years later [] . Kidney disease in most of patients with ANCA-vasculitis gives only few signs and symptoms. Microhematuria, granulated urinary cylinders, proteinuria, worsening of renal function and hypertension were signs of kidney damage. Findings of p-ANCA (MPO-ANCA) antibodies in serum of a patient is connected with necrotising small-vessels vasculitis (idiopathic necrotising glomerulonephritis with crescents as vasculitis limited on kidney, microscopic poliangiits, Churg-Strauss syndrome) but it could be found with necrotising vasculitis of small and medium blood vessels like periarteritis nodosa. In our patient we considered possibility of overlapping these diff erent types of vasculitis. Treatment of small vessels vasculitis caused by ANCA antybodies includes immunosupresive therapy leading to the remission in most of cases. Intensity of therapy must be ad- justed to the severity of the disease [] . Th e most common subdivision based on the diagnosis includes two subgroups: without or with minimal involvement of kidneys, with moderate kidney involvement (creatinine < μmol/L) or with severe kidney damage (creatinine >  μmol/L). Using standard treatment approach with combination of cyclophosphamide and corticosteroides lead to remission in more than  patients and one-year survival rate is more than . During maintenance phase azathioprin is used instead of cyclophosphamide [] . For group of patients with severe kidney disease, where prognosis is the worst, it is recommending additional treatment with plasma exchange (x liters) or with pulse doses of metilprednisolone (x gram per day intravenously). Immunosupresive maintenance therapy could be used as long as two years. Main causes of early mortality are infections and late mortality is mainly caused with progressive cicatrisation after repeated fl ares of vasculitis and toxic eff ects of drugs [] .
CONCLUSIONS
Results from clinical and laboratory tests can support an immune ANCA vasculitis, but kidney biopsy and histopathology examination is necessary for early and exact diagnosis of ANCA vasculitis microscopic polyangiitis type with ANCA-associated glomerulonephritis, as well as early starting of therapy, which determined outcome of disease. Polyneuropathy of lower extremities presented much more before kidney symptomatology could be a first manifestation of an atypical presentation of MPA.
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